Startups & growth Analysis
CpG Diagnostics develops a blood test for a difficult ovarian-mass decision
CpG Diagnostics is developing OvaPrint to help clinicians assess an ovarian-area mass before treatment, with clinical validation underway.
CD
MoneyMakers coverage
CpG Diagnostics: news & coverage
Page 1 of 1 · 1 report
CpG Diagnostics is developing a blood test to help clinicians assess ovarian-area masses before treatment.
Published reporting on CpG Diagnostics. Entries describe developments as reported on their publication dates.
All reporting
